BR9910120A - Compostos de espisulosina tendo atividade antitumor - Google Patents

Compostos de espisulosina tendo atividade antitumor

Info

Publication number
BR9910120A
BR9910120A BR9910120-3A BR9910120A BR9910120A BR 9910120 A BR9910120 A BR 9910120A BR 9910120 A BR9910120 A BR 9910120A BR 9910120 A BR9910120 A BR 9910120A
Authority
BR
Brazil
Prior art keywords
compounds
spisulosin
antitumor activity
activity
mollusc
Prior art date
Application number
BR9910120-3A
Other languages
English (en)
Portuguese (pt)
Inventor
Kenneth Lloyd Rinehart
Nancy Louise Fregeau
Robert Arthur Warwick
Dolores Garcia Gravalos
Jesus Avila
Glynn Thomas Faircloth
Original Assignee
Univ Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Illinois filed Critical Univ Illinois
Publication of BR9910120A publication Critical patent/BR9910120A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/08—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with only one hydroxy group and one amino group bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Fodder In General (AREA)
BR9910120-3A 1998-04-10 1999-04-09 Compostos de espisulosina tendo atividade antitumor BR9910120A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/058,456 US6107520A (en) 1997-04-15 1998-04-10 Spisulosine compounds
PCT/GB1999/001091 WO1999052521A1 (en) 1998-04-10 1999-04-09 Spisulosine compounds having antitumour activity

Publications (1)

Publication Number Publication Date
BR9910120A true BR9910120A (pt) 2000-12-26

Family

ID=22016916

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9910120-3A BR9910120A (pt) 1998-04-10 1999-04-09 Compostos de espisulosina tendo atividade antitumor

Country Status (24)

Country Link
US (1) US6107520A (ja)
EP (1) EP1069894B1 (ja)
JP (1) JP2002511410A (ja)
KR (1) KR100568964B1 (ja)
CN (1) CN1335770A (ja)
AT (1) ATE303139T1 (ja)
AU (1) AU763981B2 (ja)
BG (1) BG64970B1 (ja)
BR (1) BR9910120A (ja)
CA (1) CA2328126A1 (ja)
DE (1) DE69927007T2 (ja)
DK (1) DK1069894T3 (ja)
ES (1) ES2248995T3 (ja)
HK (1) HK1042048A1 (ja)
HU (1) HUP0105443A3 (ja)
IL (1) IL138886A0 (ja)
MX (1) MXPA00009930A (ja)
NO (1) NO20005052L (ja)
PL (1) PL343381A1 (ja)
RU (1) RU2225710C2 (ja)
SK (1) SK15082000A3 (ja)
TR (1) TR200002955T2 (ja)
UA (1) UA72208C2 (ja)
WO (1) WO1999052521A1 (ja)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6306911B1 (en) * 2000-02-07 2001-10-23 Ortho-Mcneil Pharmaceutical, Inc. Substituted amino acids as neutral sphingomyelinase inhibitors
KR20020092958A (ko) * 2000-02-16 2002-12-12 파르마 마르.에스.에이. 항종양 활성을 가진 옥시- 및 아미노-치환된테트라하이드로푸릴 유도체
AU2001262518B2 (en) * 2000-06-06 2006-10-26 Pharma Mar, S.A. Antitumoral compounds
FR2811556B1 (fr) * 2000-07-11 2002-09-06 Oreal Composition comprenant un precurseur de ceramides, utilisation pour ameliorer l'epiderme naturel ou reconstruit , equivalent de peau obtenu
US7563810B2 (en) 2002-11-06 2009-07-21 Celgene Corporation Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
US8034831B2 (en) 2002-11-06 2011-10-11 Celgene Corporation Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
WO2004064713A2 (en) * 2003-01-20 2004-08-05 Vib Vzw The use of yop preoteins or rho gtpase inhibitors as caspase-1 inhibitors
CN100360515C (zh) * 2004-04-09 2008-01-09 中国科学院上海药物研究所 抗肿瘤活性成份陵水醇、制备方法和用途
WO2006034849A1 (en) * 2004-09-27 2006-04-06 Pharma Mar, S.A., Sociedad Unipersonal Antitumoral pharmaceutical compositions comprising a spisulosine and a cyclodextrin
RU2010101416A (ru) * 2007-06-19 2011-07-27 Такеда Фармасьютикал Компани Лимитед (Jp) Профилактическое/лекарственное средство от рака
CN102206163B (zh) * 2011-05-06 2013-07-10 中国海洋大学 一种长链碱的分离制备方法
WO2014118556A2 (en) * 2013-01-31 2014-08-07 Research Foundation Of The City University Of New York Selective inhibitors and allosteric activators of sphingosine kinase
CN104758275A (zh) * 2015-03-05 2015-07-08 青岛申达高新技术开发有限公司 一种治疗结肠癌的药物组合物及其应用
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام
CN112063606A (zh) * 2020-08-25 2020-12-11 山东省科学院生物研究所 一种快速提取贝类消化内源酶的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816450A (en) * 1986-09-15 1989-03-28 Duke University Inhibition of protein kinase C by long-chain bases
US5190876A (en) * 1988-12-27 1993-03-02 Emory University Method of modifying cellular differentiation and function and compositions therefor
CA2007507C (en) * 1989-02-03 1998-05-19 Yasuyuki Igarashi Sphingosine and n-methyl-sphingosine as inhibitor of cell growth
US5583160A (en) * 1989-02-03 1996-12-10 The Biomembrane Institute Methylsphingosine used to treat apoptosis
US5426228A (en) * 1994-06-27 1995-06-20 Koskinen; Ari General method for preparation of sphingosine bases and their analogues
EP0821068A3 (en) * 1996-03-29 1999-06-02 Rohm And Haas Company Novel sphingolipids and a process thereto

Also Published As

Publication number Publication date
TR200002955T2 (tr) 2001-01-22
DK1069894T3 (da) 2006-01-09
KR20010074483A (ko) 2001-08-04
IL138886A0 (en) 2001-11-25
HUP0105443A3 (en) 2005-07-28
CA2328126A1 (en) 1999-10-21
KR100568964B1 (ko) 2006-04-07
DE69927007T2 (de) 2006-06-29
AU763981B2 (en) 2003-08-07
EP1069894A1 (en) 2001-01-24
NO20005052D0 (no) 2000-10-06
WO1999052521A1 (en) 1999-10-21
AU3432199A (en) 1999-11-01
SK15082000A3 (sk) 2001-08-06
BG104935A (en) 2001-07-31
EP1069894B1 (en) 2005-08-31
MXPA00009930A (es) 2002-04-24
HK1042048A1 (zh) 2002-08-02
US6107520A (en) 2000-08-22
UA72208C2 (en) 2005-02-15
BG64970B1 (bg) 2006-11-30
CN1335770A (zh) 2002-02-13
ES2248995T3 (es) 2006-03-16
NO20005052L (no) 2000-12-07
HUP0105443A1 (hu) 2002-07-29
JP2002511410A (ja) 2002-04-16
PL343381A1 (en) 2001-08-13
DE69927007D1 (de) 2005-10-06
ATE303139T1 (de) 2005-09-15
RU2225710C2 (ru) 2004-03-20

Similar Documents

Publication Publication Date Title
BR9910120A (pt) Compostos de espisulosina tendo atividade antitumor
BR9909242A (pt) Inibidores de fosfolipase a2
ES2195970T3 (es) L-ribavirina y usos de la misma.
DE69739665D1 (de) Isoliertes, dimerisches fibroblasten-aktivierendes protein alpha und anwendungen desselben
BR9913658A (pt) Frações de inulina, processo para a sua preparação e produtos alimentìcios contendo as ditas frações de inulina
TR200000782T2 (tr) Resorsinol türevleri.
BR9713147A (pt) Benzamidoaldeìdo, uso do mesmo, benzamida, e, preparação medicamentosa para administração oral, parenteral ou intraperitoneal.
BR9910180A (pt) Composição farmacêutica, processos para o tratamento de uma condição associada com a transmissão reduzida de nicotina, para identificação de um modulador positivo de um agonista receptor nicotìnico e para identificação de um composto, composto, e, uso de um modulador positivo de um agonista receptor nicotìnico
BR9913156A (pt) Composição e processo para condicionamento, clareamento e realce do cabelo
BR9909819A (pt) Amida, uso de amidas, e, preparação farmacêutica para uso oral, parenteral ou intraperitoneal
ATE303362T1 (de) Chalcon-derivate mit antiproliferativer aktivität
DE59805601D1 (de) Hängebahn, insbesondere Einschienen-Elektrohängebahn
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
ES2195586T3 (es) Almidon modificado, estable respecto a la sal.
FR2720137B1 (fr) Attache de fixation de câbles, tuyauteries ou analogues.
DE69725459D1 (de) Substituierte 1,2,3,4-tetrahydro-2-dibenzofuranamine und 2-aminocyclohepta(b)benzofurane
EA200000160A1 (ru) Новые соли с полезными органолептическими свойствами
ATE335091T1 (de) Bc200 rna, daraus abgeleitete proben und entsprechende anwendungen
ES2174150T3 (es) Procedimiento para la obtencion de 4-hidroxianilinas.
TR200003203T2 (tr) Karboksaldehitin saflaştırılması
FR2776060B1 (fr) Mine, notamment antichar ou antivehicule, comportant des moyens de confirmation de la presence d'une cible
ATE331733T1 (de) Metallhaltige ribonukleotidpolypeptide
BR9915589A (pt) Uso de derivados de azabicicloalcano n-substituìdo
BR9903278A (pt) Chocolate ou revestimento composto
BR0112460A (pt) Método para tratamento de sépsis

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: ALTERADO DE INT.CL: A61K 31/13; A61K 35/56; A61P 35/00

Ipc: A61K 31/13 (2008.01), A61K 35/56 (2008.01), A61K 3

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI